Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Share News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 514.00
Bid: 491.00
Ask: 516.00
Change: 24.00 (4.90%)
Spread: 25.00 (5.092%)
Open: 490.00
High: 514.00
Low: 490.00
Prev. Close: 490.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Gooch & Housego Reports Improved Demand With Growth In Order Book

Wed, 19th Feb 2020 09:06

(Alliance News) - Gooch & Housego PLC on Wednesday expressed confident outlook going forward as demand for its products increased in the first four months of its current financial year.

The AIM stock was 6.3% higher in early trade in London at 1,360.44 pence a share.

Ahead of its annual general meeting, the Somerset-headquartered manufacturer of photonic components and systems said it saw a high demand for fibre couplers used in undersea cables during the four months to the end of January.

In addition, Gooch & Housego said it expects to experience an improved demand in industrial laser end markets and new laser-based manufacturing techniques.

Elsewhere, the company said the impact of the coronavirus is difficult to quantify at this stage, given factories in China are only just reopening after an extended New Year holiday, but it may act as a "drag" on THE semiconductors sector's short-term performance.

Looking ahead, Gooch & Housego said it expects to show progress on last year's result and intends to continue to monitor the potential impact of the coronavirus on its industrial laser products.

As at the end of January, the company's order book was GBP94.1 million compared to GBP91.4 million a year prior, up 3%.

"We remain confident in the long term growth potential for our chosen photonic technologies in all of our target sectors," said Chief Executive Mark Webster.

"Gooch & Housego will continue to pursue further progress on our long term goals of greater diversification and moving up the value chain," added Webster.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Jun 2015 08:00

Gooch & Housego Interim Profit Boosted By Industrial Revenue Growth

Read more
9 Jun 2015 07:52

Tuesday broker round-up

Reed Elsevier: Barclays ups target price to 1,225p and lifts recommendation to overweight from equal-weight. HSBC Holdings: Investec reiterates hold and 620p target. Bernstein keeps target price at 650p. Goldman Sachs places estimates under review. Credit Suisse reiterates underperform and 580p targ

Read more
9 Jun 2015 05:28

Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Jun 2015 16:00

LONDON MARKET CLOSE: FTSE 100 Ends Down; Takeover Rumours Drive Stocks

Read more
8 Jun 2015 14:56

Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Jun 2015 05:33

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Jun 2015 15:03

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Jun 2015 05:21

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Jun 2015 15:22

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Jun 2015 05:11

Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Jun 2015 15:03

Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Jun 2015 05:14

Earnings, Trading Statements Calendar - Week Ahead

Read more
2 Jun 2015 15:25

Earnings, Trading Statements Calendar - Week Ahead

Read more
2 Jun 2015 14:55

Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Apr 2015 16:42

Wednesday broker round-up:

AstraZeneca: Morgan Stanley lifts target price to 4,500p from 4,300p, reiterates underweight. BG Group: Canaccord Genuity improves target price to 1,300p from 1,016p and downgrades to hold. GlaxoSmithKline: Deutsche Bank raises target price to 1,600p from 1,300p and reiterates hold. Tate&Lyle: Num

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.